nsys Therapeutics Inc (INSY) stock is down -14.5% over the last 30 days and has fallen -39.71% over the last 12 months. The average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives INSY stock a score of 40 out of a possible 100.
That score is primarily influenced by a long-term technical score of 14. INSY’s score also includes a fundamental score of 52. In addition to the average rating from Wall Street analysts, INSY stock has a mean target price of $7.60. This means analysts expect the stock to increase 84.02% over the next 12 months. The short-term technical score for INSY is 54.
What’s Happening with INSY Stock Today
Insys Therapeutics Inc (INSY) stock is down -3.5% while the S&P 500 has fallen -0.02% as of 10:40 AM on Wednesday, May 8. INSY has fallen -$0.15 from the previous closing price of $4.28 on volume of 43,377 shares. Over the past year the S&P 500 is higher by 7.89% while INSY has fallen -39.71%. INSY lost -$1.68 per share in the over the last 12 months.